亚太药业(002370.SZ)：拟向星浩控股定增募资不超过7亿元

Core Viewpoint - Asia Pacific Pharmaceutical (002370.SZ) plans to raise a total of up to RMB 700 million through a private placement of shares, with all proceeds allocated for new drug research and development projects [1] Group 1: Fundraising Details - The company intends to issue shares to a specific group, namely Zhejiang Xinghao Holding Partnership (Limited Partnership), which will subscribe to the shares in cash [1] - The agreement for share subscription was signed on October 13, 2025, with conditions for effectiveness [1] Group 2: Agreements and Partnerships - The controlling shareholder, Fubon Group, and its wholly-owned subsidiary, Hangu Investment, have signed a share transfer agreement with Xinghao Holding and its concerted party, Xingchen Investment [1] - Xinghao Holding and its concerted party, Xingchen Investment, have also signed a concerted action agreement and a voting rights entrustment agreement [1]